Rasph

Chrysalix to Lixea: An EIC Accelerator Story of Wood Biorefining

October 7, 20262,474 words13 min

Chrysalix Technologies Estonia OÜ was a Tallinn company with no sales, set up in August 2019 by a London spin-out of Imperial College to bring a chemistry for dissolving waste wood into the European Union. Two months later the European Commission's list of EIC Accelerator pilot winners for the 9 October 2019 cut-off named it, alone and with no partner company, for Bioflex, "Second life of wood: BioFlex technology to dissolve waste wood to get raw materials", with blended finance. The EU contributed €2,318,662.50 towards a total cost of €3,797,203.75, according to CORDIS, and the EIC Fund added €2 million as a convertible loan in May 2021. The money paid for a pilot plant in Bäckhammar, Sweden, which was finished and ran trials. The Estonian company that won the award, renamed Lixea OÜ, no longer exists: its sole shareholder put it into liquidation on 18 June 2025 and it was deleted from the Estonian e-Business Register on 11 February 2026. The business carries on as Lixea, through Lixea Sweden AB and the London parent Lixea Limited.

€2.32MEU grant for Bioflex
€2MEIC Fund convertible loan, May 2021
13Sawdust batches run in the pilot plant by August 2022
ClosedEstonian winner deleted, 11 February 2026

Company file

Award winner
Chrysalix Technologies Estonia OÜ, later Lixea OÜ, registry code 14780817, Tallinn; registered 13 August 2019, deleted 11 February 2026
Parent
Lixea Limited, London, company 10839236, incorporated 28 June 2017 as Chrysalix Technologies Limited
Operating company today
Lixea Sweden AB, 559337-3912, registered 28 September 2021, pilot plant in Bäckhammar near Kristinehamn
Founders
Jason Hallett, Florence Gschwend, Agi Brandt-Talbot (Imperial College London)
Leadership
Marcus Elmer, acting CEO; Krisztina Kovacs-Schreiner, CEO until a date not made public, now an advisor
Known backers
EIC Fund; a Swedish investor from July 2023 (named by neither the company nor the filings read)
Staff
7 in Estonia (2022 average); 6 at Lixea Sweden AB (2024)
EIC project
Bioflex, CORDIS 946203, June 2020 to August 2022, blended finance

Where the Company Stands Now

The Estonian company was a vehicle. Its annual reports explain that the London company, then still called Chrysalix Technologies Limited, created it because of Brexit and because the United Kingdom lacked the wood processing industries the technology needed. Its 2023 annual report says that in July 2023 Lixea secured investment from an investor based in Sweden, after which management moved the whole business to Lixea Sweden AB: all assets, the intellectual property and the pilot plant equipment, were sold to the Swedish company for one euro, and the 2024 report adds that the €2 million EIC Fund convertible loan was moved onto the Swedish company's balance sheet as well. With nothing left to do, the Estonian company lost €1,626 in 2024, went into liquidation in June 2025 and was deleted in February 2026; Inforegister records the same deletion date and lists its former name, Chrysalix Technologies Estonia OÜ.

The group is still filing and operating. Lixea Limited is listed as active at Companies House, where it filed micro-company accounts for 2025 and a confirmation statement in July 2026; its filing history also shows that Krisztina Kovacs-Schreiner, the chief executive named in Imperial's press releases, left its board on 10 May 2026. Lixea's team page now lists Marcus Elmer as acting CEO and Kovacs-Schreiner as an advisor. Lixea Sweden AB is registered as active, with Elmer as external managing director and Ernst & Young as auditor, according to Ratsit, which draws on the Swedish Companies Registration Office and lists LSCS Invest AB as the parent of the group the Swedish company belongs to. No other source read for this article names the 2023 investor.

The Technology: A Salt That Dissolves Wood

The process, first called BioFlex and renamed Dendronic during the EIC project, uses ionic liquids, salts that are liquid at low temperature, to take wood apart into its main components: cellulose, lignin and hemicelluloses. Chrysalix was founded in 2017 by Jason Hallett and Florence Gschwend of Imperial's chemical engineering department and Agi Brandt-Talbot of its chemistry department, according to Imperial College London. Conventional pulp mills are built for clean wood and aim mainly at cellulose. The company's pitch, in the CORDIS objective, is that its solvent copes with "any kind of woody material", including waste wood contaminated with metals, paint or preservatives that would otherwise be burned or landfilled, and that it recovers both cellulose and lignin for chemicals, plastics, fuels and materials. A 2025 profile by the Society of Chemical Industry adds that it can process treated wood while recovering copper and arsenic.

"This funding will allow us to produce BioFlex cellulose and lignin at the tonne scale."

Jason Hallett, co-founder, Imperial College London news, 12 December 2019

What the EIC Project Promised, and What the Record Shows

The grant agreement was signed on 24 May 2020 and the project ran from 1 June 2020 to 31 August 2022, according to CORDIS. Of the EU contribution, €1,837,500 went to the Estonian coordinator, €413,612.50 to Lixea Limited in London and €67,550 to Lixea Sweden AB, both of which took part as linked third parties rather than as named winners. The aim, as the final periodic report puts it, was "to demonstrate the Lixea technology at a pilot scale" and to develop markets and value chains for its products.

The pilot plant was built. The periodic report says it was "constructed and fully commissioned" and had processed its first 13 batches of waste sawdust from a local mill in Sweden, with the cellulose and lignin analysed and shared with potential customers. The Estonian annual reports date its completion to May 2022, and Region Värmland also says it was completed in 2022. The SCI profile, by contrast, says the Swedish pilot plant "came on stream during 2024". A CORDIS results article reports that the team turned the cellulose into moulded fibre packaging such as egg cartons and food trays, made fermentation sugars for bioethanol from sawmill residues, and made moulded fibre and furfural from sugar cane bagasse. The company also registered DENDRONIC as a UK trademark on 2 June 2021, listed among the project results. The report counts 9 jobs created, 6 of them in rural areas, contacts with more than 120 companies and more than 30 potential investors.

What the record does not show is the commercial step the project described. The CORDIS objective said the company had "established a clear timeline for commercialization and signed a number of agreements with partners". No licensee, offtake contract or paying industrial customer has been announced, and no tonne-scale output figure has been published. The CORDIS results article ends with Lixea "exploring partnerships with a view to launching a demonstration plant". Estonia's research information portal ETIS is indexed by search engines with the project running from June 2020 to May 2022, three months shorter than the CORDIS dates; the portal could not be reached for this article, so whether the end date was extended could not be verified.

  1. Build and commission a pilot plantDeliveredBäckhammar, completed May 2022, per CORDIS.
  2. Demonstrate value chains for cellulose and ligninDeliveredPackaging, sugars and furfural trials, per the CORDIS results article.
  3. Tonne-scale productionNot verified13 batches reported; no volumes published.
  4. Commercial partners and licenseesNot achievedNone announced four years after the project ended.
  5. Demonstration plantFunded, not built€21.5M Innovation Fund grant; financial close set for March 2027.

The Equity Side: Was the EIC Fund Money Invested?

Yes. Imperial reported on 24 May 2021 that Lixea had "closed a €2 million investment" from the EIC Fund pilot, and the EIB Institute repeated the figure in June 2021. The Estonian annual reports describe it as a €2 million convertible loan received in May 2021 to cover the 30% of project costs the grant did not pay, plus running costs. The EIC Fund's list of invested companies includes Lixea, but under its Swedish entity: the portfolio entry names Lixea Sweden AB, consistent with the loan being moved to Sweden in 2023. Lixea's own news post on the same €2 million carries the date 23 February 2024, almost three years later; Imperial, the EIB and the company's Estonian accounts all date the money to May 2021. Whether the loan has been converted into shares is not public.

A different description

Region Värmland describes the pilot plant as financed by a "€4.3 million EU grant". The public record shows €2.32 million of EU grant money and a €2 million EIC Fund loan, which together come to €4.32 million.

The Money

The Estonian company never had sales. It lost €333,094 in its first period to the end of 2020, €1,513,239 in 2021 and €1,377,963 in 2022, and employed an average of 7 people in 2022, according to its filings in the e-Business Register. In 2023 it reported a profit of €3,223,972: once the grant project closed in January 2023, it booked €3,431,341 of EU grant money as income, money its balance sheet had until then carried as a liability. By the end of 2023 it had no staff and no liabilities left.

The Swedish successor is small and losing more each year. Lixea Sweden AB had sales of SEK 3.2 million in 2024, up from SEK 2.1 million in 2023, and a loss of SEK 15.4 million, up from SEK 4.4 million, with 6 employees and equity of minus SEK 7.9 million, according to Ratsit; Allabolag gives the same 2024 sales of SEK 3,156,000, a loss after financial items of SEK 15,434,000 and an equity ratio of minus 28%. The two sites disagree on EBITDA, which Ratsit puts at SEK 2.9 million and Allabolag at minus SEK 10.2 million, so it is left out here. Region Värmland reports SEK 2 million of sales in 2023 and 8 employees. Accounts for 2025 were not yet published in either source.

The big new money is a grant. On 27 March 2025 Imperial reported a €21.5 million award from the EU Innovation Fund for L1X, a first-of-its-kind demonstration plant, and Global Trade Alert records the grant to Lixea Sweden AB as of 3 March 2025. According to Lixea, the plant is to process 25,000 dry tonnes a year of agricultural and forestry side streams in Central Slovakia, with financial close planned for 31 March 2027 and operations from 30 June 2029. Lixea has not announced who else will finance the plant. Raising private money has been the weak point before: Imperial's December 2019 announcement of the EIC award said the grant would be accompanied by additional investment from the European Investment Bank and other investors, but Hallett told the SCI that the funding round, set for early 2020, was cancelled when the pandemic began: "Suddenly we had lost our investors."

Why Europe Should Care

Turning residues into materials is the core of the EU's bioeconomy policy. The Commission adopted a new bioeconomy strategy on 27 November 2025, with scaling innovation and investment and creating lead markets for bio-based products among its four priorities, according to ERA Portal Austria and Euresearch. A process that takes contaminated demolition wood, which today is burned or landfilled, and returns lignin and cellulose would fit that agenda and cut reliance on fossil feedstocks for chemicals. With the Innovation Fund grant, Lixea also received the Strategic Technologies for Europe (STEP) Seal, Imperial reported. The geography of the award is a product of Brexit: the EU money went to an Estonian company created because the UK parent was leaving the Union, the pilot plant was built in Sweden, and the next plant is planned for Slovakia.

What the company said

Tonne-scale cellulose and lignin from waste wood, signed partner agreements and a clear timeline to commercialisation.

What the record shows

A working pilot plant and product trials, no announced customer, a Swedish successor with growing losses and negative equity, and a grant-backed demonstration plant still to be financed.

The Verdict

Pilot built, award winner gone

The EIC money did what a grant can do: Lixea built a pilot plant in Sweden and tested its products. The Estonian company that won the award was emptied in 2023 and deleted in 2026, and the technology now depends on a loss-making Swedish company raising the rest of the money for its first commercial-scale plant.

Lixea and the EIC have not been asked for comment for this article. It is based on public records and published statements, linked throughout.

Industry

Materials and chemicalsBio-based materials

Focus
  • Biorefinery products
Technologies
  • Biorefining
  • Separation technology
Keywords
  • Ionic liquids
  • Wood waste
  • Cellulose
  • Hemicellulose
  • Solvent fractionation

Start with the EIC Accelerator

Expert review for Step 1 and Step 2, suitability assessment and grant screening.

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges is a new pilot program offering €300,000 (Stage 1) and up to €2.5 million (Stage 2) for breakthrough deep-tech solutions through ARPA-style staged funding with demand-side integration. The program targets single entities or small consortia (2-3 partners) including SMEs, start-ups, and research organizations. Focus areas include Physical AI for autonomous robotics and New Approach Methodologies (NAMs) for animal-free biomedical testing, requiring TRL 4 entry with end-user commitment.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
EIC AcceleratorBeneficiary Deep Dive#Chrysalix Technologies#Lixea#biorefining#waste wood#lignin#ionic liquids#Estonia#Sweden
Loading